Search results for "bone marrow cells"

showing 10 items of 120 documents

Effects of Conjugated Linoleic Acid and Endurance Training on Peripheral Blood and Bone Marrow of Trained Mice

2007

Fat supplements, especially conjugated linoleic acid (CLA), are increasingly popular ergogenic aids among endurance athletes. To evaluate the importance of fat supplementation in the practice of endurance sports, we investigated the effects of CLA supplementation on body weight, muscle hypertrophy, peripheral blood composition, and bone marrow composition in healthy, young, endurance-trained mice. Young, healthy mice were subdivided into control, trained, and treated groups, according to their running attitudes. Training was performed over a period of 6 weeks on a treadmill, at a gradually increasing duration and speed. CLA-treated groups were gavaged with 0.425 mg x d(-1) CLA supplement fo…

Malelinoleic acidmedicine.medical_specialtyConjugated linoleic acidPhysical Therapy Sports Therapy and RehabilitationBone Marrow Cellsmedicine.disease_causeMuscle hypertrophychemistry.chemical_compoundMiceEndurance trainingInternal medicinePhysical Conditioning AnimalmedicineAnimalsOrthopedics and Sports MedicineLinoleic Acids ConjugatedTreadmillMuscle SkeletalAnalysis of Variancebusiness.industryBody WeightGeneral MedicineNeutrophiliaBlood Cell CountOxidative StressEndocrinologymedicine.anatomical_structurechemistryPhysical EnduranceBone marrowAnalysis of variancemedicine.symptombusinessOxidative stress
researchProduct

Induction of anamnestic T cell proliferation by antigen-pulsed, bone marrow-derived macrophages.

1981

Bone marrow-derived macrophages (BMM phi) were grown in a liquid culture system in the presence of L cell-conditioned medium as a source of colony-stimulating factor. After a 4-h pulse with antigen, cultured irradiated BMM phi were capable of presenting the antigen to primed T cells as assessed in a T cell proliferation assay. Proliferation was optimal when BMM phi were used between days 5 and 8 of bone marrow cell culture. T cells of Lyt1 and Lyt123 phenotype had to be present at the start of the culture period to yield an optimal response. Conventional antisera and monoclonal antibodies directed against the H-2 I region and the I-A subregion, respectively, proved inhibitory in this system…

Malemedicine.drug_classT cellT-LymphocytesImmunologyGenes MHC Class IIDose-Response Relationship ImmunologicBone Marrow CellsCell CountMice Inbred StrainsBiologyMonoclonal antibodyLymphocyte ActivationAntibodiesEpitopesMiceAntigenmedicineCell AdhesionImmunology and AllergyCytotoxic T cellAnimalsAntigensAntigen-presenting cellCells CulturedImmune response geneMacrophagesHistocompatibility Antigens Class IIMolecular biologymedicine.anatomical_structurePhenotypeImmunologyAntigens SurfaceMyeloid-derived Suppressor CellFemaleBone marrowEuropean journal of immunology
researchProduct

Mesenchymal Stem Cells Improve Motor Functions and Decrease Neurodegeneration in Ataxic Mice

2014

The main objective of this work is to demonstrate the feasibility of using bone marrow-derived stem cells in treating a neurodegenerative disorder such as Friedreich's ataxia. In this disease, the dorsal root ganglia of the spinal cord are the first to degenerate. Two groups of mice were injected intrathecally with mesenchymal stem cells isolated from either wild-type or Fxntm1Mkn/Tg(FXN)YG8Pook (YG8) mice. As a result, both groups presented improved motor skills compared to nontreated mice. Also, frataxin expression was increased in the dorsal root ganglia of the treated groups, along with lower expression of the apoptotic markers analyzed. Furthermore, the injected stem cells expressed th…

Malemedicine.medical_specialtyAtaxiaCellular differentiationGene ExpressionBone Marrow CellsMice TransgenicMotor ActivityMesenchymal Stem Cell TransplantationTransplantation AutologousMiceGlutathione Peroxidase GPX1Neurotrophin 3Internal medicineGanglia SpinalIron-Binding ProteinsDrug DiscoverymedicineGeneticsAnimalsTransplantation HomologousNerve Growth FactorsMolecular BiologyInjections SpinalPharmacologyGlutathione PeroxidasebiologyBrain-Derived Neurotrophic FactorMesenchymal stem cellCell DifferentiationMesenchymal Stem CellsAnatomySpinal cordCatalaseDisease Models AnimalEndocrinologymedicine.anatomical_structureFriedreich AtaxiaFrataxinbiology.proteinMolecular MedicineOriginal ArticleFemaleBone marrowmedicine.symptomStem cellAdult stem cell
researchProduct

Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction

2008

Aims In clinical studies on cell therapy for acute myocardial infarction (MI), cells are usually applied by intracoronary infusion with balloon (IC/B). To test the utility of balloon occlusion, mononuclear bone marrow cell (MNC) retention after intracoronary infusion without balloon (IC/noB) was compared with IC/B and intramyocardial (IM) injection. Methods and results Four hours after LAD ligation in male pigs, reperfusion was allowed (confirmed by coronary angiography). Five days later, 1 × 108 autologous 111Indium-labelled MNC were injected IC/noB ( n = 4), IC/B ( n = 4), or IM ( n = 4). At 1 h the fraction of injected MNC that was detected in the heart was 4.1 ± 1.1% after IC/noB inject…

Malemedicine.medical_specialtyPathologySwineMyocardial InfarctionUrologyBone Marrow CellsMyocardial ReperfusionCoronary AngiographyBalloonPeripheral blood mononuclear cellReperfusion therapySuidaemedicineAnimalsMyocardial infarctionBone Marrow TransplantationMicroscopy Confocalbiologybusiness.industryBalloon Occlusionmedicine.diseasebiology.organism_classificationmedicine.anatomical_structureInjections Intra-ArterialCirculatory systemBone marrowCardiology and Cardiovascular MedicinebusinessIntramuscular injectionTomography Emission-ComputedEuropean Heart Journal
researchProduct

Characterization of a T-cell-derived mast cell costimulatory activity (MCA) that acts synergistically with interleukin 3 and interleukin 4 on the gro…

1990

The proliferation of mucosal mast cells (MMC) depends on the presence of interleukin 3 (IL 3) and can be further enhanced by interleukin 4 (IL 4). The supernatant of a TH2 cell clone (ST2/K.9) stimulated by concanavalin A was found to contain a factor, provisionally termed mast cell costimulatory activity (MCA), that substantially enhances the proliferation of MMC promoted by a combination of IL 3 and IL 4. In comparison to other lymphokines MCA is rather resistant to tryptic digestion but is very sensitive to pH values lower than 6.0 and to organic solvents. Chromatographic fractionation of MCA revealed that activity is associated with protein(s) or glycoprotein(s) of 35 to 40 kDa. Partial…

Malemedicine.medical_specialtyT-LymphocytesImmunologyBone Marrow CellsBiologyBiochemistryMast cell proliferationCell LineBiological FactorsMiceEpidermal growth factorInternal medicinemedicineImmunology and AllergyAnimalsMast CellsMolecular BiologyInterleukin 4Interleukin 3LymphokinesLymphokineDrug SynergismHematologyMast cellHematopoietic Stem CellsMolecular biologyClone Cellsmedicine.anatomical_structureEndocrinologyMice Inbred DBAChromatography GelCytokinesTumor necrosis factor alphaFemaleInterleukin-3Interleukin-4Leukemia inhibitory factorCell DivisionCytokine
researchProduct

Targeting cells of the immune system: mannosylated HPMA–LMA block-copolymer micelles for targeting of dendritic cells

2016

Background: Successful tumor immunotherapy depends on the induction of strong and sustained tumor antigen-specific immune responses by activated antigen-presenting cells (APCs) such as dendritic cells (DCs). Since nanoparticles have the potential to codeliver tumor-specific antigen and DC-stimulating adjuvant in a DC-targeting manner, we wanted to assess the suitability of mannosylated HPMA-LMA block polymers for immunotherapy. Materials & methods: Fluorescence-labeled block copolymer micelles derived from P(HPMA)-block-P(LMA) copolymers and according statistical copolymers were synthesized via RAFT polymerization, and loaded with the APC activator L18-MDP. Both types of copolymers wer…

Materials sciencePolymersSurface Propertiesmedicine.medical_treatmentBiomedical EngineeringMedicine (miscellaneous)Bone Marrow CellsBioengineering02 engineering and technologyDevelopment01 natural sciencesMicellePolymerizationImmune systemAntigenmedicineHumansGeneral Materials ScienceReversible addition−fragmentation chain-transfer polymerizationMicelles010405 organic chemistryDendritic CellsImmunotherapyDendritic cell021001 nanoscience & nanotechnologyMolecular biology0104 chemical sciencesCell biologyMethacrylatesNanoparticlesImmunotherapy0210 nano-technologyAcetylmuramyl-Alanyl-IsoglutamineMannoseAdjuvantSpleenMannose receptorNanomedicine
researchProduct

Immobilization of BMP‐2, BMP‐7 and alendronic acid on titanium surfaces: Adhesion, proliferation and differentiation of bone marrow‐derived stem cells

2019

This study analyzed the influence of titanium (TiO2 ) surface modifications with two osteogenic proteins (BMP-2, BMP-7) and an anti-osteoclastic drug (alendronic acid [AA]) on sandblasted/acid-etched (SLA) and plain TiO2 (PT) on cell adhesion, proliferation and differentiation (alkaline phosphatase [AP] and osteocalcin [OC]) of bone-marrow derived stem cells (BMSCs) after 1, 3 and 7 days in-vitro. Initially, AA surfaces showed the highest cell number and surface coverage. At day 3 and 7, BMP and AA-modified surfaces exhibited a significantly enhanced cell growth. For proliferation, at days 3 and 7, an enhancement on BMP-2, BMP-7 and AA-surfaces was seen. At day 7, SLA also showed a higher p…

Materials scienceSurface PropertiesBone Morphogenetic Protein 70206 medical engineeringBiomedical EngineeringBone Morphogenetic Protein 2Biocompatible MaterialsBone Marrow Cells02 engineering and technologyBone morphogenetic protein 2BiomaterialsOsteogenesisCell AdhesionmedicineHumansCell adhesionCells CulturedCell ProliferationTitaniumAlendronateBone Density Conservation AgentsbiologyCell growthStem CellsAlendronic acidfungiMetals and AlloysCell DifferentiationAdhesion021001 nanoscience & nanotechnology020601 biomedical engineeringMolecular biologyImmobilized Proteinsmedicine.anatomical_structureembryonic structuresCeramics and CompositesOsteocalcinbiology.proteinAlkaline phosphataseBone marrow0210 nano-technologymedicine.drugJournal of Biomedical Materials Research Part A
researchProduct

Modulation of accessory cell function of immortalized bone marrow-derived macrophages by granulocyte/macrophage colony-stimulating factor.

1993

To generate cloned macrophage populations with sensitivity towards granulocyte/macrophage colony-stimulating factor (GM-CSF), bone marrow-derived macrophages (BMM phi) were immortalized by transformation with SV40. A panel of transformed clones was established. The majority of clones represented independently derived transformants, as evidenced by restriction fragment length polymorphism using genomic DNA digested with EcoRI and TaqI and the 5.2 kb SV40 DNA for hybridization analysis. The cells belong to the macrophage lineage according to several criteria, e.g. the presence of nonspecific esterase, their phagocytic capacity and their morphology. Many clones were potent antigen-presenting c…

Microbiology (medical)ImmunologyAntigen presentationAntigen-Presenting CellsBone Marrow CellsSimian virus 40BiologyGranulocyteMicePhagocytosismedicineImmunology and AllergyMacrophageAnimalsAntigen-presenting cellCells CulturedMice Inbred C3HMacrophage Colony-Stimulating FactorMacrophagesHistocompatibility Antigens Class IIGranulocyte-Macrophage Colony-Stimulating FactorGeneral MedicineBlotting NorthernCell Transformation ViralMolecular biologyClone CellsBlotmedicine.anatomical_structureGranulocyte macrophage colony-stimulating factorCell cultureImmunologyDNA ViralBone marrowDNA ProbesPolymorphism Restriction Fragment Lengthmedicine.drugMedical microbiology and immunology
researchProduct

Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral c…

1998

Effective control by the immune system is a hallmark of cytomegalovirus (CMV) infection. Accordingly, human CMV disease is a medical problem restricted to the immunologically immature or immunocompromised host (for a review, see reference 21). Murine models have implicated natural killer (NK) cells and CD8 T cells in the control of CMV infection. While NK cells mediate early protection in genetically resistant mouse inbred strains (4, 5, 31, 51), CD8 T cells establish enduring protective memory and function as principal antiviral effectors in susceptible strains (31). Specifically, in the BALB/c strain, major histocompatibility complex (MHC) class I-restricted antiviral CD8 T cells resolve …

MuromegalovirusAdoptive cell transferImmunologyViral Pathogenesis and ImmunityBone Marrow CellsImmunodominanceVirus ReplicationMajor histocompatibility complexMicrobiologyImmediate-Early ProteinsMiceImmune systemAntigenVirologyMHC class IAnimalsCytotoxic T cellLungAntigen PresentationMice Inbred BALB CbiologyImmunodominant EpitopesAntigen processingvirus diseasesHerpesviridae InfectionsVirologyKineticsInsect ScienceImmunologyTrans-Activatorsbiology.proteinFemaleT-Lymphocytes Cytotoxic
researchProduct

The suppressive effects of recombinant human tumor necrosis factor‐alpha on normal and malignant myelopoiesis: Synergism with interferon‐gamma

1988

The modulation of growth of normal and leukemic myeloid progenitor cells in soft agar cultures by recombinant human tumor necrosis factor-alpha (TNF alpha) and recombinant human interferon-gamma (IFN gamma) was investigated. TNF alpha inhibited colony formation of all colony types representing different maturational stages of normal progenitor cells committed to the myeloid lineage with different orders of sensitivity. Blast-type colonies derived from patients with acute myelogenous leukemia were more sensitive to TNF alpha inhibition than progenitor cells purified from normal bone marrow or bone marrow from patients with stable-phase chronic myelogenous leukemia. The response of most colon…

MyeloidBone Marrow CellsBiologyInterferon-gammaBone MarrowmedicineHumansInterferon gammaProgenitor cellTumor Necrosis Factor-alphaAntibodies MonoclonalDrug SynergismCell BiologyHematopoietic Stem Cellsmedicine.diseaseRecombinant ProteinsLeukemia Myeloid AcuteLeukemiamedicine.anatomical_structureLeukemia MyeloidImmunologyCancer researchTumor necrosis factor alphaBone marrowMyelopoiesisChronic myelogenous leukemiamedicine.drugThe International Journal of Cell Cloning
researchProduct